COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 174 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,852,000 | +4.2% | 664,519 | +0.2% | 0.01% | 0.0% |
| Q2 2023 | $14,256,101 | -11.2% | 663,383 | -0.9% | 0.01% | 0.0% |
| Q1 2023 | $16,060,993 | -15.5% | 669,487 | -18.3% | 0.01% | -28.6% |
| Q4 2022 | $19,014,998 | +45.3% | 819,612 | +0.3% | 0.01% | +40.0% |
| Q3 2022 | $13,087,000 | -15.1% | 816,926 | -6.1% | 0.01% | 0.0% |
| Q2 2022 | $15,422,000 | -12.4% | 870,306 | +0.6% | 0.01% | 0.0% |
| Q1 2022 | $17,607,000 | +11.9% | 864,782 | +2.7% | 0.01% | +25.0% |
| Q4 2021 | $15,736,000 | -3.0% | 842,381 | +2.5% | 0.00% | -20.0% |
| Q3 2021 | $16,221,000 | -17.6% | 821,747 | -1.3% | 0.01% | -16.7% |
| Q2 2021 | $19,682,000 | +29.1% | 832,554 | +29.4% | 0.01% | +20.0% |
| Q1 2021 | $15,247,000 | +15.4% | 643,322 | -2.5% | 0.01% | +25.0% |
| Q4 2020 | $13,215,000 | -2.3% | 659,739 | +1.5% | 0.00% | -20.0% |
| Q3 2020 | $13,529,000 | +15.9% | 649,799 | -2.6% | 0.01% | 0.0% |
| Q2 2020 | $11,671,000 | +47.8% | 666,918 | +37.9% | 0.01% | +25.0% |
| Q1 2020 | $7,897,000 | -22.3% | 483,566 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $10,169,000 | +50.6% | 494,138 | -16.0% | 0.00% | +33.3% |
| Q3 2019 | $6,752,000 | -13.0% | 588,145 | -0.4% | 0.00% | 0.0% |
| Q2 2019 | $7,764,000 | -12.6% | 590,392 | +0.6% | 0.00% | -25.0% |
| Q1 2019 | $8,886,000 | -22.0% | 586,942 | -11.5% | 0.00% | -20.0% |
| Q4 2018 | $11,392,000 | +19.0% | 663,498 | +2.1% | 0.01% | +25.0% |
| Q3 2018 | $9,575,000 | -4.3% | 649,624 | +54.8% | 0.00% | 0.0% |
| Q2 2018 | $10,009,000 | -5.3% | 419,656 | +1.4% | 0.00% | -20.0% |
| Q1 2018 | $10,574,000 | +27.5% | 413,838 | -7.9% | 0.01% | +66.7% |
| Q4 2017 | $8,293,000 | +17.5% | 449,265 | -33.2% | 0.00% | 0.0% |
| Q3 2017 | $7,056,000 | -15.6% | 672,627 | +0.6% | 0.00% | -25.0% |
| Q2 2017 | $8,364,000 | +29.9% | 668,558 | +4.4% | 0.00% | +33.3% |
| Q1 2017 | $6,440,000 | -7.9% | 640,189 | +42.5% | 0.00% | 0.0% |
| Q4 2016 | $6,993,000 | -28.7% | 449,127 | -11.8% | 0.00% | -40.0% |
| Q3 2016 | $9,803,000 | +65.3% | 508,995 | +1.7% | 0.01% | +66.7% |
| Q2 2016 | $5,929,000 | -9.8% | 500,309 | +38.2% | 0.00% | 0.0% |
| Q1 2016 | $6,570,000 | -33.2% | 362,004 | +1.2% | 0.00% | -40.0% |
| Q4 2015 | $9,833,000 | +23.5% | 357,584 | -0.7% | 0.01% | +25.0% |
| Q3 2015 | $7,959,000 | -99.9% | 359,966 | -26.3% | 0.00% | 0.0% |
| Q2 2015 | $8,715,019,000 | – | 488,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |